Observational studyPloS one2020

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study.

Robin D Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.